Evolutionary Tree Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Evolutionary Tree Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-132,484	Closed	-$1.95M	–	45
2022 Q1	$1.95M	Sell	132,484 -10,931	-8%	-$146K	1.35%	30
2021 Q4	$2.27M	Buy	143,415 +53,997	+60%	+$1.3M	1.09%	31
2021 Q3	$2.87M	Buy	89,418 +10,839	+14%	+$381K	1.27%	33
2021 Q2	$3.27M	Buy	78,579 +24,978	+47%	+$1.03M	1.51%	29
2021 Q1	$2.72M	Buy	+53,601	New	+$2.8M	1.61%	26

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Evolutionary Tree Capital Management's DMTK Position: Q2 2022 in Review

Evolutionary Tree Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 132,484 shares — an estimated $1.95M sold.

Evolutionary Tree Capital Management first reported a position in DMTK in Q1 2021 and held it in 5 quarters. The position peaked at $3.27M in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

Evolutionary Tree Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Evolutionary Tree Capital Management sold 132,484 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $1.95M.
Evolutionary Tree Capital Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Evolutionary Tree Capital Management's DermTech, Inc. Common Stock position peaked at $3.27M in Q2 2021.
134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Evolutionary Tree Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.